Recombinant factor IX (BAX326) in previously treated paediatric patients with haemophilia B: a prospective clinical trial.

Urasinski, T; Stasyshyn, O; Andreeva, T; Rusen, L; Perina, F G; Oh, M S; Chapman, M; Pavlova, B G; Valenta-Singer, B; Abbuehl, B E

Urasinski, T; Stasyshyn, O; Andreeva, T; Rusen, L; Perina, F G; Oh, M S; Chapman, M; Pavlova, B G; Valenta-Singer, B; Abbuehl, B E.

Affiliation

Urasinski T; Department of Paediatrics, Paediatric Haematology and Oncology, Pomeranian Medical University in Szczecin, Szczecin, Poland.
Stasyshyn O; Institute of Blood Pathology and Transfusion Medicine of the Academy of Medical Sciences of Ukraine, Lviv, Ukraine.
Andreeva T; Republican Center for Haemophilia Treatment, St. Petersburg, Russia.
Rusen L; Prof. Dr. C. T. Nicolau National Institute for Transfusional Hematology, Bucharest, Romania.
Perina FG; Regional Clinical Hospital, Ekaterinburg, Russia.
Oh MS; Baxter BioScience, Westlake Village, CA, USA.
Chapman M; Baxter BioScience, Vienna, Austria.
Pavlova BG; Baxter BioScience, Vienna, Austria.
Valenta-Singer B; Baxter BioScience, Vienna, Austria.
Abbuehl BE; Baxter BioScience, Vienna, Austria.

Haemophilia ; 21(2): 196-203, 2015 Mar.

Article de En | MEDLINE | ID: mdl-25495591

Sujet(s)
Mots clés

haemophilia B; paediatric; previously treated patients; recombinant factor IX

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Protéines recombinantes / Facteur IX / Hémophilie B Type d'étude: Clinical_trials / Etiology_studies / Risk_factors_studies Limites: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Langue: En Journal: Haemophilia Sujet du journal: HEMATOLOGIA Année: 2015 Type de document: Article Pays d'affiliation: Pologne Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google